Challenges in Inferring Pneumococcal Conjugate Vaccine Impact From Bacterial Surveillance Data-Reference-Cited by-同舟云学术

Challenges in Inferring Pneumococcal Conjugate Vaccine Impact From Bacterial Surveillance Data

Published:2022-07-28 Issue:2 Volume:227 Page:304-305
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Deloria Knoll Maria¹,Bennett Julia C¹,Yang Yangyupei¹,Garcia Quesada Maria¹

Affiliation:

1. Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland , USA

Funder

World Health Organization

Bill & Melinda Gates Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiac323/45415575/jiac323.pdf

Reference7 articles.

1. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in the Gambia: 10 years of population-based surveillance;Mackenzie;Lancet Infect Dis,2021

2. Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study;Hammitt;Lancet,2019

3. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study;Cohen;Lancet Global Health,2017

4. The global landscape of pediatric bacterial meningitis data reported to the World Health Organization–coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014–2019;Nakamura;J Infect Dis,2021

5. Serotype distribution of remaining pneumococcal meningitis in the mature PCV10/13 period: findings from the PSERENADE project;Garcia Quesada;Microorganisms,2021